Sensitive Colorimetric Detection of Interleukin-6 via Lateral Flow Assay Incorporated Silver Amplification Method

Mohammad Rahbar1, Yuling Wu2, J Anand Subramony3

  • 1Graduate School of Biomedical Engineering, The University of New South Wales, Kensington, NSW, Australia.

Insights

A new lateral flow assay enables sensitive, low-cost detection of Interleukin-6 (IL-6) using gold nanoparticles and silver amplification. This point-of-care test offers a user-friendly alternative for diagnosing inflammatory diseases.

Area of Science:

  • Biomedical Engineering
  • Immunotechnology
  • Point-of-Care Diagnostics

Background:

  • Interleukin-6 (IL-6) is a critical cytokine for diagnosing inflammatory diseases.
  • Existing IL-6 detection methods are costly, time-consuming, and complex.
  • A need exists for a reliable, user-friendly, and low-cost point-of-care (POC) IL-6 detection platform.

Purpose of the Study:

  • To develop a novel lateral flow assay for sensitive and quantitative colorimetric detection of IL-6.
  • To improve upon existing diagnostic methods by creating a user-friendly and cost-effective POC test.
  • To validate the assay's performance for IL-6 detection in human serum.

Main Methods:

  • Development of a lateral flow assay utilizing anti-IL-6 antibodies conjugated to gold nanoparticles (AuNPs).
  • Incorporation of a silver amplification technique to enhance colorimetric signal intensity.
  • Testing and validation of the assay using human serum samples within physiological ranges (5-1000 pg/mL).

Main Results:

  • Achieved a sensitive limit of detection of 5 pg/mL for IL-6 in serum with silver amplification.
  • Demonstrated enhanced colorimetric signals compared to standard assays.
  • Confirmed assay reliability through specificity and reproducibility tests for quantitative IL-6 measurement.

Conclusions:

  • The developed lateral flow assay provides a sensitive, reliable, and user-friendly POC method for IL-6 detection.
  • Silver amplification significantly improves the detection limit, making it suitable for clinical diagnostics.
  • This assay represents a promising advancement for the rapid diagnosis of IL-6-associated inflammatory conditions.